Welcome to Week 3

Welcome to the third week of this four-week course on Intravenous (IV) to Oral [Antimicrobial] Switch Therapy (IVOST) and the monitoring of complex oral antimicrobial regimens within the Outpatient Parenteral Antibiotic Therapy (OPAT) setting.

Last week we considered how to prescribe and monitor Linezolid. This week we will move on to consider the monitoring of some of the other oral antimicrobials we commonly prescribe and monitor at the COPAT service here in Hull. By the end of the week we hope you will have ascertained or consolidated a basic but robust framework so you can extend the principles of monitoring the oral antimicrobials discussed in weeks 2 and 3 to other antimicrobial agents.

As before, I strongly encourage you to engage with your fellow learners during the week by using the comments facility in each step. I hope you have a great week.

If you have any feedback on the week, please let us know.

Gavin Barlow

Main learning outcomes for week 3:

  • Understand the principles and concepts of prescribing different complex oral antimicrobials and regimens within the OPAT setting.

  • Understand the adverse effects and other problems associated with prescribing various complex oral antimicrobials and regimens and how to mitigate for these.

  • Think about and reflect on how to extrapolate and apply the above learned principles and concepts to other antimicrobial agents and areas of antimicrobial prescribing practice.

Share this article:

This article is from the free online course:

Intravenous to Oral Switch: Within Outpatient Parenteral Antibiotic Therapy (IVOST)


Get a taste of this course

Find out what this course is like by previewing some of the course steps before you join: